TCR2 Therapeutics (TCRR) PEG Ratio

Price: $1.48
Market Cap: $58.11M
Avg Volume: 325.04K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.93322
52W Range: $0.821-3.88
Website: TCR2 Therapeutics

PEG Ratio Summary

  • TCR2 Therapeutics's trailing twelve month (TTM) PEG ratio is 0.00.
  • TCR2 Therapeutics's annual PEG ratio as of today is -0.01.
  • TCR2 Therapeutics's quarterly PEG ratio is 0.01.

What is the PEG Ratio?

The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.

How is the PEG Ratio calculated?

The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:

PEG Ratio = (P/E Ratio) / (EPS Growth Rate)

This helps investors to determine a stock's value while considering the company's earnings growth.

Related Metrics

Other important metrics to assess TCR2 Therapeutics's financial health include:

  • P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
    • Annual: -0.25
    • Quarterly: -0.36
    • TTM: -0.38
  • P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
    • Annual: 0.00
    • Quarterly: 0.00
    • TTM: 0.00
  • P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
    • Annual: 0.27
    • Quarterly: 0.58
    • TTM: 0.41
  • P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
    • Annual: -0.38
    • Quarterly: -1.47
    • TTM: -0.56

These metrics provide insights into TCR2 Therapeutics's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

TTM PEG Ratio

0.00

Annual PEG Ratio

-0.01

Quarterly PEG Ratio

0.01

TCR2 Therapeutics Historical PEG Ratio

1.001.000.000.00-1.00-1.00-2.00-2.00-3.00-3.00PEG Ratio-0.01-0.18-2.08-0.050.24-0.180.0020172017201820182019201920202020202120212022202220232023

Historical P/E Ratio

0.000.00-4.00-4.00-8.00-8.00-12.00-12.00-16.00-16.00P/E Ratio-0.25-1.77-12.90-6.33-14.41-5.92-7.8020172017201820182019201920202020202120212022202220232023

Historical P/S Ratio

InfinityInfinity0.000.00P/S Ratio0.000.000.000.000.000.000.0020172017201820182019201920202020202120212022202220232023

Historical P/B Ratio

6.006.003.003.000.000.00-3.00-3.00-6.00-6.00-9.00-9.00P/B Ratio0.270.633.661.88-4.08-2.94-6.5120172017201820182019201920202020202120212022202220232023

Historical P/CF Ratio

0.000.00-5.00-5.00-10.00-10.00-15.00-15.00-20.00-20.00P/CF Ratio-0.38-2.17-15.26-7.29-18.61-6.43-8.2520172017201820182019201920202020202120212022202220232023

TCR2 Therapeutics Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2022.

Year PEG Ratio P/E Ratio P/S Ratio P/B Ratio P/CF Ratio
2022 -0.01 -0.25 0.00 0.27 -0.38
2021 -0.18 -1.77 0.00 0.63 -2.17
2020 -2.08 -12.90 0.00 3.66 -15.26
2019 -0.05 -6.33 0.00 1.88 -7.29
2018 0.24 -14.41 0.00 -4.08 -18.61
2017 -0.18 -5.92 0.00 -2.94 -6.43
2016 0.00 -7.80 0.00 -6.51 -8.25

Related Metrics

Explore detailed financial metrics and analysis for TCRR.